BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16425359)

  • 1. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience.
    Conio M; Repici A; Cestari R; Blanchi S; Lapertosa G; Missale G; Della Casa D; Villanacci V; Calandri PG; Filiberti R
    World J Gastroenterol; 2005 Nov; 11(42):6650-5. PubMed ID: 16425359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
    Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
    Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer.
    Thota PN; Sada A; Sanaka MR; Jang S; Lopez R; Goldblum JR; Liu X; Dumot JA; Vargo J; Zuccarro G
    Surg Endosc; 2017 Mar; 31(3):1336-1341. PubMed ID: 27444824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.
    Lada MJ; Watson TJ; Shakoor A; Nieman DR; Han M; Tschoner A; Peyre CG; Jones CE; Peters JH
    Semin Thorac Cardiovasc Surg; 2014; 26(4):274-84. PubMed ID: 25837538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent or recurrent Barrett's neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue.
    Bowman CJ; Zhang R; Balitzer D; Wang D; Rabinovitch PS; Kővári BP; Mattis AN; Kakar S; Lauwers GY; Choi WT
    Mod Pathol; 2021 Oct; 34(10):1889-1900. PubMed ID: 34108638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
    Yachimski P; Puricelli WP; Nishioka NS
    Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus.
    Small AJ; Sutherland SE; Hightower JS; Guarner-Argente C; Furth EE; Kochman ML; Forde KA; Bewtra M; Falk GW; Ginsberg GG
    Gastrointest Endosc; 2015 May; 81(5):1158-66.e1-4. PubMed ID: 25650071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of endoscopic ultrasound findings on clinical decision making in Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
    Bulsiewicz WJ; Dellon ES; Rogers AJ; Pasricha S; Madanick RD; Grimm IS; Shaheen NJ
    Dis Esophagus; 2014 Jul; 27(5):409-17. PubMed ID: 23016606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia.
    Konda VJ; Gonzalez Haba Ruiz M; Koons A; Hart J; Xiao SY; Siddiqui UD; Ferguson MK; Posner M; Patti MG; Waxman I
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2002-10.e1-2. PubMed ID: 24732285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system.
    Gondrie JJ; Pouw RE; Sondermeijer CM; Peters FP; Curvers WL; Rosmolen WD; Ten Kate F; Fockens P; Bergman JJ
    Endoscopy; 2008 May; 40(5):370-9. PubMed ID: 18494132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic mucosal resection versus esophagectomy for intramucosal adenocarcinoma in the setting of barrett's esophagus.
    Li C; Yamashita DT; Hawel JD; Bethune D; Henteleff H; Ellsmere J
    Surg Endosc; 2017 Oct; 31(10):4211-4216. PubMed ID: 28342132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus.
    Ayers K; Shi C; Washington K; Yachimski P
    Surg Endosc; 2013 Aug; 27(8):2836-40. PubMed ID: 23389078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of conventional endosonography and endoscopic ultrasound-guided fine-needle aspiration in the assessment of patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma who have been referred for endoscopic ablation therapy.
    Shami VM; Villaverde A; Stearns L; Chi KD; Kinney TP; Rogers GB; Dye CE; Waxman I
    Endoscopy; 2006 Feb; 38(2):157-61. PubMed ID: 16479423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus.
    Evans JA; Poneros JM; Bouma BE; Bressner J; Halpern EF; Shishkov M; Lauwers GY; Mino-Kenudson M; Nishioka NS; Tearney GJ
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):38-43. PubMed ID: 16431303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients.
    Giovannini M; Bories E; Pesenti C; Moutardier V; Monges G; Danisi C; Lelong B; Delpero JR
    Endoscopy; 2004 Sep; 36(9):782-7. PubMed ID: 15326573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after liquid nitrogen spray cryotherapy in Barrett's esophagus-associated high-grade dysplasia and intramucosal adenocarcinoma: 5-year follow-up.
    Ramay FH; Cui Q; Greenwald BD
    Gastrointest Endosc; 2017 Oct; 86(4):626-632. PubMed ID: 28235596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.